Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.

Clinical pharmacology and therapeutics - 1 Apr 2014

Van Driest S L, Shi Y, Bowton E A, Schildcrout J S, Peterson J F, Pulley J, Denny J C, Roden D M

Abstract excerpt

Since September 2010, more than 10,000 patients have undergone preemptive, panel-based pharmacogenomic testing through the Vanderbilt Pharmacogenomic Resource for Enhanced Decisions in Care and Treatment program. Analysis of the genetic data from the first 9,589 individuals reveals that the frequency of genetic variants is concordant with published allele frequencies. Based on five currently implemented drug-gene...

Topics

Join the communities discussing this publication.

Aged
Black or African American
Gene Frequency
Genetic Testing
Genetic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Pharmacogenetics

Pharmacogenetics and Drug Metabolism

Source

Open in PubMed Open full text

Identifiers

PMID: 24253661
DOI: 10.1038/clpt.2013.229
PMCID: PMC3961508

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.PMID 24253661Read ↗

Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.Semantic proximity Read ↗

Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.Semantic proximity Read ↗

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.Semantic proximity Read ↗

Experience with comprehensive pharmacogenomic multi-gene panel in clinical practice: a retrospective single-center study.Semantic proximity Read ↗

Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.Semantic proximity Read ↗

CLINICAL IMPLEMENTATION OF PREEMPTIVE PHARMACOGENOMICS TESTING FOR PERSONALIZED MEDICINE AT AN ACADEMIC MEDICAL CENTERSemantic proximity Read ↗

Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.Semantic proximity Read ↗

Pharmacogenetic Panel Testing: A Review of Current Practice and Potential for Clinical ImplementationSemantic proximity Read ↗

How to Transition from Single‐Gene Pharmacogenetic Testing to Preemptive Panel‐Based Testing: A TutorialSemantic proximity Read ↗

Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.Semantic proximity Read ↗

Avoidable drug-gene conflicts and polypharmacy interactions in patients participating in a personalized medicine program.Semantic proximity Read ↗

A retrospective analysis of preemptive pharmacogenomic testing in 22,918 individuals from China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.